SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Gao Tian) srt2:(2005-2009)"

Sökning: WFRF:(Gao Tian) > (2005-2009)

  • Resultat 1-7 av 7
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Chen, Ruikui, et al. (författare)
  • Photoinduced intramolecular charge-transfer state in thiophene-π-conjugated donor-acceptor molecules.
  • 2008
  • Ingår i: Journal of Molecular Structure. - : Elsevier BV. - 0022-2860 .- 1872-8014. ; 876:1-3, s. 102-109
  • Tidskriftsartikel (refereegranskat)abstract
    • Novel thiophene-π-conjugated donor-acceptor mols., 5-[2-(1,2,2,4-tetramethyl-1,2,3,4-tetrahydroquinolin-6-yl)-vinyl]-thiophene-2-carbaldehyde (QTC) and (1-cyano-2-{5-[2-(1,2,2,4-tetramethyl-1,2,3,4-tetrahydroquinolin-6-yl)-vinyl]-thiophen-2-yl}-vinyl)-phosphonic acid di-Et ester (QTCP), were designed and synthesized. Combined exptl. and theor. methods were performed to investigate the photoinduced intramol. charge-transfer (ICT) processes of these compds. Steady-state absorption and fluorescence measurements in different solvents indicate the photoinduced ICT characters of QTC and QTCP. Solvent dependency of the large Stokes shifts and high dipole moment of the excited state also support the charge-transfer character of the excited state. Theor. calcns. based on time-dependent d. functional theory (TDDFT) method were performed to investigate ICT states of these compds. The results reveal that the excited states have adopted a distortion of the C=C double bond between the donor moiety and the thiophene-π-bridge. [on SciFinder(R)]
  •  
2.
  • Cheng, LT, et al. (författare)
  • Sex difference in the prevalence of left ventricular hypertrophy in dialysis patients
  • 2009
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 29:5, s. 398-405
  • Tidskriftsartikel (refereegranskat)abstract
    • <i>Background:</i> Left ventricular hypertrophy (LVH) is an important, independent negative predictor of cardiovascular morbidity and mortality in the general population and in dialysis patients. Previous studies suggest a sex dimorphism in the prevalence of LVH; however, this issue has never been approached in dialysis patients. <i>Methods:</i> This study enrolled 237 prevalent dialysis patients: 49 on hemodialysis (HD) and 188 on peritoneal dialysis (PD) from a single center. LVH was defined by echocardiography measurements, which were normalized to body surface area (BSA) and height<sup>2.7</sup>, respectively. <i>Results:</i> The mean ages in HD and PD patients were 60 ± 14 and 60 ± 13 years, with a median dialysis vintage of 43 and 20 months, respectively. Although there was no significant difference in age, diabetes, proportion of uncontrolled hypertension, antihypertensive medication and blood pressure between male and female patients within each dialysis modality, the prevalence of LVH (whether indexed to BSA or height<sup>2.7</sup>) was consistently higher in females than in males. When these patients were divided into LVH or non-LVH groups, a significant difference in sex distribution was observed between the two groups (62.0% vs. 41.0% when the BSA-indexed standard was used, p < 0.01; 62.8% vs. 37.1% when the height<sup>2.7</sup>-indexed standard was used, p < 0.001). In logistic regression analysis, female sex was identified as a risk factor of LVH (odds ratio, OR = 2.48, 95% confidence interval, CI = 1.33–4.59; when BSA-indexed LVH was treated as dependent variable, and OR = 4.05, 95% CI = 1.96–8.38, when height<sup>2.7</sup>-indexed LVH was treated as dependent variable) even after adjustment for age, diabetes, blood pressure and antihypertensive medication. <i>Conclusion:</i> This study showed that the prevalence of LVH determined by echocardiography was significantly higher in female dialysis patients than in male dialysis patients. Compared with males, female patients had a 2.5- to 4-fold higher risk to develop LVH even after adjustment for other potential confounding factors, which may indicate that elderly females in the uremic scenario are more prone to develop LVH than elderly males.
  •  
3.
  • Gao, Aiping, et al. (författare)
  • Asymmetric oxidation of sulfides catalyzed by chiral (salen)Mn(III) complexes with a pyrrolidine backbone
  • 2006
  • Ingår i: Applied organometallic chemistry. - : Wiley. - 0268-2605 .- 1099-0739. ; 20:12, s. 830-834
  • Tidskriftsartikel (refereegranskat)abstract
    • Catalytic properties of a series of chiral (pyrrolidine salen)Mn(III) complexes for asymmetric oxidation of aryl methyl sulfides were evaluated. Moderate activity, good chemical selectivity and low enantioselectivity were attained with iodosylbenzene as a terminal oxidant. Enantioselectivity of sulfide oxidation was affected slightly by polar solvent and the sulfoxidation carried out in THF for thioanisole and in CH3CO2Et for electron-deficient sulfides gave better enatioselctivities. The addition of the donor ligand PPNO (4-phenylpyridine N-oxide) or MNO (trimethylamine N-oxide) only has a minor positive effect on the enantioselectivity. Also explored was the steric effect of the N-aza-substituent in the backbone of (pyrrolidine salen)Mn(III) complexes on the enantioselectivity of sulfide oxidation. The sulfides' access pathway is discussed based on the catalytic results.
  •  
4.
  • Gao, Aiping, et al. (författare)
  • Asymmetric oxidation of sulfides catalyzed by vanadium(IV) complexes of dibromo- and diiodo-functionalized chiral Schiff bases
  • 2006
  • Ingår i: Cuihuà xuébào. - 0253-9837 .- 1872-2067. ; 27:8, s. 743-748
  • Tidskriftsartikel (refereegranskat)abstract
    • The catalyst system of VO(acac)(2) and Schiff base ligands derived from 3,5-dibromo- or 3,5-diiodosalicylaldehyde and inexpensive chiral amino alcohols was prepared. This catalyst displayed good yields and moderate to high enantioselectivity for the asymmetric oxidation of aryl methyl sulfides at room temperature when 1% catalyst (VO(acac)(2)/ligand molar ratio of 1: 2) and H2O2 Oxidant were used. The ligands derived from ( S)valinol exhibited considerably higher enantioselectivity than those ligands derived from ( S)-phenylalaninol and (R)-leucinol. The enantiomeric excess values were improved up to 88% for methyl phenyl sulfoxide and 92% for methyl p-bromophenyl sulfoxide by slow dropwise addition of H2O2 with the ligand prepared from 3 15-diiodosalicylaldehyde and (s)-valinol. The present study showed that the catalytic efficiency of VO(acac)(2) /Schiff base systems could not be improved by the addition of carboxylic acids or carboxylate salts.
  •  
5.
  • Su, Min, et al. (författare)
  • Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely high-risk area in China
  • 2007
  • Ingår i: European Journal of Epidemiology. - : Springer Science and Business Media LLC. - 1573-7284 .- 0393-2990. ; 22:1, s. 43-48
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of our study was to investigate the temporal malignant tumor incidence rates among the 70,000 residents at the relatively isolated Nanao Island in South China Sea. The data on all malignant tumor cases from Nanao Cancer Registry during 1995-2004 were coded, computerized, and analyzed using the software SPSS10.0. The tumor incident cases, crude incident rate, age-standardized incidence rate, their sex distribution and temporal trend were assessed. A total of 1450 new cancer cases (990 males and 460 females) were identified. The annual average age-standardized incidence rate (ASR) of malignant tumors was 208.18/100,000. The age-standardized incidence rate of the ten leading cancers in both sexes combined per 100,000 population were 74.47 for esophageal cancer (EC), 34.81 for cardiac cancer (CC), 25.66 for liver cancer, 26.01 for lung cancer, 18.52 for stomach cancer, 4.45 for nasopharyngeal cancer, 3.91 for breast cancer, 2.53 for colon/rectum cancer, 2.45 for bladder cancer and 1.92 for pancreatic cancer. These ten types of cancers make up to 93% of all cancer cases, with EC and CC being the most prevalent and making up 52% of the total cases. The incidence rates of esophagus, liver, lung, breast, nasopharyngeal, and colon/rectum cancers showed increasing trends during the period from 1995 to 2004 in Nanao Island. Astounding the EC ASR were 72-150/100,000 among male and 26-64/100,000 among female in Nanao Island during 1995-2004. The EC incidence rate in Nanao population is among the highest across the world, which suggests that there are potential genetic and/or environmental factors affecting this particular population.
  •  
6.
  • Yan, H, et al. (författare)
  • Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors
  • 2005
  • Ingår i: Biochemical and Biophysical Research Communications. - : Elsevier BV. - 1090-2104 .- 0006-291X. ; 336:1, s. 287-298
  • Tidskriftsartikel (refereegranskat)abstract
    • Recombinant adeno-associated virus serotype 2 (rAAV2) vector has been widely employed for gene therapy. Recent progress suggests that the new serotypes of AAV showed a better performance than did AAV2 in normal tissues. Here, we evaluate the potential role of human vascular endothelial growth factor (VEGF) gene transfer using rAAV vector pseudotyped with serotype I capsid proteins (rAAV1) in the treatment of muscle ischemia. In ischemic skeletal muscles, the rAAV1-LacZ vector allowed higher level, broader distribution, and long-lasting gene expression compared with the rAAV2-LacZ vector. Muscle VEGF165 production following the rAAV1-VEGF165 vector injection was 5-10 times higher than that following the rAAV2-VEGF165 vector injection. VEGF165 production mediated by the rAAV1-VEGF165 vector stimulated a large set of neovascularization with relatively mature vascular structures and enhanced muscle regeneration in the ischemic skeletal muscles. Thus, the rAAV1-NEGF165 vector mediated gene transfer may be a therapeutic approach to peripheral vascular diseases.
  •  
7.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-7 av 7

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy